BD and Waters announced an agreement to create a new life science and diagnostics leader through a business combination.

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.

2025 年 7 月 14 日，美国马萨诸塞州，全球分析仪器领导者 Waters Corporation（纽约证券交易所代码：WAT）宣布，已与医疗技术巨头 Becton, Dickinson & ...

BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through ...

BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.

Shares of Waters Corporation (NYSE:WAT) declined 2.2% following the announcement of a $17.5 billion Reverse Morris Trust deal ...

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

2025年7月14日，美国马萨诸塞州，全球分析仪器领导者Waters Corporation（纽约证券交易所代码：WAT）宣布，已与医疗技术巨头Becton, Dickinson & Company（BD，纽约证券交易所代码：BDX）达成最终协议，将整合BD旗下生物科学及诊断解决方案业务。此次交易通过反向莫里斯信托（Reverse Morris ...

Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

本次并购将成为 2025 ...

Waters Corporation (WAT) stock downgraded at Wells Fargo based on execution risks related to its $17.5B M&A deal with a unit of Becton Dickinson (BDX). Read more here;.

Waters plans to combine with the Biosciences & Diagnostic Solutions business of BD (Becton, Dickinson & Co.), the companies said, in a $17.5 billion deal that would be the year’s largest within life ...